Immunisation programmes are foundational to public health. Organised by health authorities, they systematically deliver ...

Health Technology Assessment (HTA) agencies evaluate and make decisions on the use, funding, or reimbursement of health technologies based on clinical and economic evidence. Economic evaluations can ...

As part of EuroQol’s current priority-setting work, the development of bolt-ons for the EQ-5D-5L instrument has taken centre stage. A “bolt-on toolbox” is being developed to identify and test ...

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Adam Raymakers and Chris Skedgel take us to Canada. Canada has a universal single-payer ...

Neil McAuslane PhD, MSc, BSc. Scientific Director of the Centre for Innovation in Regulatory Science (CIRS) overseeing the scientific content of both CIRS regulatory and HTA programmes. Key research ...

Pedro Pita Barros is the BPI | Fundação “la Caixa” Professor of Health Economics at Nova School of Business and Economics, Universidade Nova de Lisboa. He holds a PhD in Economics and his research ...

Dr Richard Torbett joined ABPI in July 2015 and previously held the role of Executive Director of Economic, Health and Commercial Policy. In this role, Richard was responsible for pricing policy ...